The cancer vaccine is custom-prepared ex vivo using patient-isolated peripheral blood mononuclear cells (PBMCs)
It will cost quite a bit as it’s autologous, but preclinical we’re positive
The cancer vaccine is custom-prepared ex vivo using patient-isolated peripheral blood mononuclear cells (PBMCs)
It will cost quite a bit as it’s autologous, but preclinical we’re positive